Gene Expression Profiling of TNBC and OVCA in response to Azacitidine and Talazoparib (RNA-Seq)
Ontology highlight
ABSTRACT: Triple negative breast cancer and ovarian cancer cells were treated with Azacitidine, Talazoparib, or combination for a period of 10 days to assess global transcriptional response. The focus of these transcriptional studies were on the assessment of DNA repair and immune pathway alteration.
ORGANISM(S): Homo sapiens
PROVIDER: GSE151317 | GEO | 2020/05/28
REPOSITORIES: GEO
ACCESS DATA